Search
for
Sort by
Research 31–60 of 1000+
- Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Advanced Diagnostic Approaches and Current Medical Management of Insulinomas and Adrenocortical Disease in Ferrets (Mustela putorius furo)
- Cortisol Enhances the Expression of mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Cultured Osteoblasts**This work was supported by NIDDK Grant DK-45227 and a scholarship (to R.C.P.) from Fundacao Coordenacao de Aperfeicoa mento de Pessoal de Nivel Superior (CAPES), Universidade de Sao Paulo (Sao Paulo, Brazil).
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Role of insulin resistance and diet in acne
- Induction of Hair Growth by Insulin-Like Growth Factor-1 in 1,763 MHz Radiofrequency-Irradiated Hair Follicle Cells
- Effect of topical application of raspberry ketone on dermal production of insulin-like growth factor-I in mice and on hair growth and skin elasticity in humans
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice
- Regulation of human dermal papilla cell production of insulin-like growth factor binding protein-3 by retinoic acid, glucocorticoids, and insulin-like growth factor-1
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Androgenetic alopecia and insulin resistance: are they truly associated?
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study
- l-Ascorbic acid 2-phosphate promotes elongation of hair shafts via the secretion of insulin-like growth factor-1 from dermal papilla cells through phosphatidylinositol 3-kinase
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Increased Vibrissa Growth in Transgenic Mice Expressing Insulin-like Growth Factor 1
- Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae
- A Clinical Approach to Severe Insulin Resistance
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance
- Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I
- Dietary isoflavone increases insulin-like growth factor-I production, thereby promoting hair growth in mice
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome